Free Trial

Focus On Offshore Developments

JPY

USD/JPY re-opened slightly higher but has trimmed gains since and last sits +9 pips at Y103.39. Both sides of the pair outperform their other G10 peers, as the space feels jitters surrounding UK Covid-19/Brexit situation. Meanwhile, U.S. Senate Majority Leader McConnell confirmed that congressional leaders have reached a deal over a $900bn economic relief package.

  • Worth noting that Sunday was a Gotobi day in Japan.
  • The Nikkei reported that Takeda plans to start a clinical trial of Moderna's Covid-19 jab in January.
  • Elsewhere, an Asahi poll showed a 17pp drop in public approval for PM Suga's cabinet, bringing it to 39% and confirming the recent trend.
  • On the topside, the initial target is provided by Y103.59, the high of Dec 18. Above there opens the 20-EMA at Y103.90. Bears look for a dip through Dec 17 low of Y102.88 before taking aim at Mar 10 low of Y102.02.
  • Focus in Japan moves to Wednesday's BoJ Oct MonPol meeting minutes & Friday's Tokyo CPI, unemployment and retail sales.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.